Table 6.
Resistance to multidrug therapy in cases of leprosy diagnosed in Japan, 2004–2020.
| Country | No. of polymerase chain reaction (+) samples tested for mutation | Mutation |
|||
|---|---|---|---|---|---|
| No mutation | fol P (dapsone) | rpo B (rifampicin) | gyr A (quinolones) | ||
|
| |||||
| Bangladesh | 1 | 1 | 0 | 0 | 0 |
| Brazil | 14 | 13 | 1 | 0 | 0 |
| Cambodia | 0 | 0 | 0 | 0 | 0 |
| East Timor | 1 | 1 | 0 | 0 | 0 |
| Indonesia | 7 | 7 | 0 | 0 | 0 |
| Japan | 7 | 7 | 0 | 0 | 0 |
| South Korea | 1 | 0 | 1 | 0 | 0 |
| Myanmar | 1 | 1 | 0 | 0 | 0 |
| Nepal | 10 | 10 | 0 | 0 | 0 |
| Philippines | 12 | 11 | 0 | 0 | 1 |
| Sri Lanka | 0 | 0 | 0 | 0 | 0 |
| Tanzania | 0 | 0 | 0 | 0 | 0 |
| Thailand | 1 | 1 | 0 | 0 | 0 |
| Viet Nam | 1 | 1 | 0 | 0 | 0 |
| Total | 56 | 53 | 2 | 0 | 1 |
| % | 100% | 94.6% | 3.6% | 0.0% | 1.8% |